TO THE EDITOR We read the study by Medeiros-Filho et al with much interest. The study shed light on early HCV RNA kinetics in conjunction with liver cirrhosis, different genotypes （gen-1 vs gen-3） of HCV and sustain...TO THE EDITOR We read the study by Medeiros-Filho et al with much interest. The study shed light on early HCV RNA kinetics in conjunction with liver cirrhosis, different genotypes （gen-1 vs gen-3） of HCV and sustained viral response （SVR） rates. In particular, Medeiros-Filho et al showed that the HCV RNA first phase decline, under interferon-or （IFN） and ribavirin therapy,展开更多
基金NIH grants RR06555 and P20-RR18754the U.S.Department of Energy under contract DE-AC52-06NA25396
文摘TO THE EDITOR We read the study by Medeiros-Filho et al with much interest. The study shed light on early HCV RNA kinetics in conjunction with liver cirrhosis, different genotypes （gen-1 vs gen-3） of HCV and sustained viral response （SVR） rates. In particular, Medeiros-Filho et al showed that the HCV RNA first phase decline, under interferon-or （IFN） and ribavirin therapy,
